BCRX fundamentals
An in-depth look to BIOCRYST PHARMACEUTICALS INC operating, investing, and financing activities
BCRX free cash flow for Q1 24 is -900.05 M MXN. For 2023, BCRX free cash flow was -1.65 B MXN and operating cash flow was -1.62 B MXN.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM